Report cover image

C5 Complement Inhibitors Global Market Report 2025

Publisher The Business Research Company
Published Sep 09, 2025
Length 250 Pages
SKU # BRC20384161

Description

C5 Complement Inhibitors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on c5 complement inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for c5 complement inhibitors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The c5 complement inhibitors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Long Acting C5 Inhibitors; Short Acting C5 Inhibitors

2) By Drug: Eculizumab; Ravulizumab; Other Drugs

3) By Route Of Administration: Intravenous; Subcutaneous; Oral

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

5) By Application: Paroxysmal Noctural Hemoglobuinuria; Atyptical Hemolytic Uremic Syndrome; Generalized Myasthenia Gravis; Neuromyelitis Optics Spectrum Disorder; Other Applications

Subsegments:

1) By Long Acting C5 Inhibitors: Crovalimab; Pozelimab; Tesidolumab; Other Long-Acting C5 Inhibitors

2) By Short Acting C5 Inhibitors: Zilucoplan; Cemdisiran; Nomacopan; Other Short-Acting C5 Inhibitors

Companies Mentioned: F. Hoffmann-La Roche AG; AstraZeneca plc; Novartis AG; Amgen Inc.; Merck KGaA; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; Chugai Pharmaceutical Co. Ltd.; UCB Pharma SA; Swedish Orphan Biovitrum AB(Sobi); Alnylam Pharmaceuticals Inc.; BioCryst Pharmaceuticals Inc.; Apellis Pharmaceuticals Inc.; Omeros Corporation; Dianthus Therapeutics Inc.; Kira Pharmaceuticals; Biopharma PEG Scientific Inc.; ProbeChem Biochemicals; InflaRx NV; Akari Therapeutics Plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. C5 Complement Inhibitors Market Characteristics
3. C5 Complement Inhibitors Market Trends And Strategies
4. C5 Complement Inhibitors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global C5 Complement Inhibitors Growth Analysis And Strategic Analysis Framework
5.1. Global C5 Complement Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global C5 Complement Inhibitors Market Growth Rate Analysis
5.4. Global C5 Complement Inhibitors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global C5 Complement Inhibitors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global C5 Complement Inhibitors Total Addressable Market (TAM)
6. C5 Complement Inhibitors Market Segmentation
6.1. Global C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long Acting C5 Inhibitors
Short Acting C5 Inhibitors
6.2. Global C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Eculizumab
Ravulizumab
Other Drugs
6.3. Global C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Subcutaneous
Oral
6.4. Global C5 Complement Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global C5 Complement Inhibitors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Paroxysmal Nocturnal Hemoglobinuria
Atypical Hemolytic Uremic Syndrome
Generalized Myasthenia Gravis
Neuromyelitis Optica Spectrum Disorder
Other Applications
6.6. Global C5 Complement Inhibitors Market, Sub-Segmentation Of Long Acting C5 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Crovalimab
Pozelimab
Tesidolumab
Other Long-Acting C5 Inhibitors
6.7. Global C5 Complement Inhibitors Market, Sub-Segmentation Of Short Acting C5 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Zilucoplan
Cemdisiran
Nomacopan
Other Short-Acting C5 Inhibitors
7. C5 Complement Inhibitors Market Regional And Country Analysis
7.1. Global C5 Complement Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global C5 Complement Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific C5 Complement Inhibitors Market
8.1. Asia-Pacific C5 Complement Inhibitors Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China C5 Complement Inhibitors Market
9.1. China C5 Complement Inhibitors Market Overview
9.2. China C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India C5 Complement Inhibitors Market
10.1. India C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan C5 Complement Inhibitors Market
11.1. Japan C5 Complement Inhibitors Market Overview
11.2. Japan C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia C5 Complement Inhibitors Market
12.1. Australia C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia C5 Complement Inhibitors Market
13.1. Indonesia C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea C5 Complement Inhibitors Market
14.1. South Korea C5 Complement Inhibitors Market Overview
14.2. South Korea C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe C5 Complement Inhibitors Market
15.1. Western Europe C5 Complement Inhibitors Market Overview
15.2. Western Europe C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK C5 Complement Inhibitors Market
16.1. UK C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany C5 Complement Inhibitors Market
17.1. Germany C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France C5 Complement Inhibitors Market
18.1. France C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy C5 Complement Inhibitors Market
19.1. Italy C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain C5 Complement Inhibitors Market
20.1. Spain C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe C5 Complement Inhibitors Market
21.1. Eastern Europe C5 Complement Inhibitors Market Overview
21.2. Eastern Europe C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia C5 Complement Inhibitors Market
22.1. Russia C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America C5 Complement Inhibitors Market
23.1. North America C5 Complement Inhibitors Market Overview
23.2. North America C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA C5 Complement Inhibitors Market
24.1. USA C5 Complement Inhibitors Market Overview
24.2. USA C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada C5 Complement Inhibitors Market
25.1. Canada C5 Complement Inhibitors Market Overview
25.2. Canada C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America C5 Complement Inhibitors Market
26.1. South America C5 Complement Inhibitors Market Overview
26.2. South America C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil C5 Complement Inhibitors Market
27.1. Brazil C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East C5 Complement Inhibitors Market
28.1. Middle East C5 Complement Inhibitors Market Overview
28.2. Middle East C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa C5 Complement Inhibitors Market
29.1. Africa C5 Complement Inhibitors Market Overview
29.2. Africa C5 Complement Inhibitors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa C5 Complement Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa C5 Complement Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. C5 Complement Inhibitors Market Competitive Landscape And Company Profiles
30.1. C5 Complement Inhibitors Market Competitive Landscape
30.2. C5 Complement Inhibitors Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
31. C5 Complement Inhibitors Market Other Major And Innovative Companies
31.1. Regeneron Pharmaceuticals Inc.
31.2. Astellas Pharma Inc.
31.3. Chugai Pharmaceutical Co. Ltd.
31.4. UCB Pharma SA
31.5. Swedish Orphan Biovitrum AB(Sobi)
31.6. Alnylam Pharmaceuticals Inc.
31.7. BioCryst Pharmaceuticals Inc.
31.8. Apellis Pharmaceuticals Inc.
31.9. Omeros Corporation
31.10. Dianthus Therapeutics Inc.
31.11. Kira Pharmaceuticals
31.12. Biopharma PEG Scientific Inc.
31.13. ProbeChem Biochemicals
31.14. InflaRx NV
31.15. Akari Therapeutics Plc
32. Global C5 Complement Inhibitors Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The C5 Complement Inhibitors Market
34. Recent Developments In The C5 Complement Inhibitors Market
35. C5 Complement Inhibitors Market High Potential Countries, Segments and Strategies
35.1 C5 Complement Inhibitors Market In 2029 - Countries Offering Most New Opportunities
35.2 C5 Complement Inhibitors Market In 2029 - Segments Offering Most New Opportunities
35.3 C5 Complement Inhibitors Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us